Intranasal WSK-IM05 Vaccine Plus Tislelizumab as Neoadjuvant Therapy for HPV+ OPSCC

Clinical trial NCT07565740 · RECRUITING

Trial details

NCT number: NCT07565740
Sponsor: West China Hospital
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

HPV-positive Oropharyngeal Squamous Cell Carcinoma

Start date: 2026-05-10
Primary completion: 2027-05-10
Enrollment: 9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.